Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome ; volume:07 ; number:04 ; year:2017 ; pages:e215-e222
AJP reports ; 07, Heft 04 (2017), e215-e222
- Contributor
-
Chavan, Niraj R.
Ashford, Kristin B.
Wiggins, Amanda T.
Lofwall, Michelle R.
Critchfield, Agatha S.
- DOI
-
10.1055/s-0037-1608783
- URN
-
urn:nbn:de:101:1-2018112306331637624763
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chavan, Niraj R.
- Ashford, Kristin B.
- Wiggins, Amanda T.
- Lofwall, Michelle R.
- Critchfield, Agatha S.
Other Objects (12)
Single high-dose buprenorphine for opioid craving during withdrawal
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice
The Role of Lofexidine in Management of Opioid Withdrawal
Single high-dose buprenorphine for opioid craving during withdrawal
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice
The Role of Lofexidine in Management of Opioid Withdrawal
Single high-dose buprenorphine for opioid craving during withdrawal
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice